San Diego, CA · Founded 2013 · Privately Held (backing)
Developer of a biotechnology platform designed to combine genomic and phenotypic information to accelerate the understanding of human health. Human Longevity is based in San Diego, CA and was founded in 2013. Its last known valuation is $250 million. It has raised $1.1 billion across 3 recorded rounds; the latest was a $32 million early-stage round in Mar 2023.
Last price · $/share
—
Implied valuation
$250.0M
Total raised
$1.1B
Last round
Early Stage VC
Mar 2023
No prints on record
No secondary trades in Human Longevity shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Human Longevity with a free account
·The complete investor list: 36 names
·Watch Human Longevity: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Human Longevity stock.
